Sourav Sinha is the Founder and CEO of Oncolinx-- an early-stage bio-oncology company developing targeted cancer therapies that avoid many of the adverse side-effects of current treatments. Oncolinx is partnered with more than 14 leading pharmaceutical companies and was named a winner of the 2014 MassChallenge startup accelerator.
Sourav is also the Entrepreneur In Residence of Gazelle Futures--a first-of-its-kind venture fund to spin out the best inventions from the NIH, NASA, DoD, DARPA, and other government funded agencies.
The World Economic Forum named Sourav as a Young Global Shaper. Sourav was also named as a top 50 global entrepreneur under the age of 25 by Inc. Magazine. Sourav has been published in top scientific journals and holds 1 patent. Sourav holds a AB from Dartmouth College in Molecular Biology and Biochemistry, and an MA in Biomedical Sciences from Rutgers Biomedical Health Sciences.
GA is excited to take you #OFFCAMPUS! Join us for this quarterly festival series that celebrates learning in a way that's fun and interactive. Day 1: ENTREPRENEURSHIP.